Regulated information

2016 Registration document

Note to recipient of this document: this is the translation of an extract of the Registration Document and Annual Financial Report for the year ended December 31, 2016. The original French document was filed with the AMF (French Financial Markets Authority) on April 26, 2017.

Présentation des résultats 2016 - french

Vétoquinol - 23.03.2017 - 18h15 - Enregistrement Audio Conference

2016 Annual Results

Présentation analystes & investisseurs - 23 mars 2017

2015 Registration document

Note to recipient of this document: this is the translation of an extract of the Registration Document and Annual Financial Report for the year ended December 31, 2015. The original French document was filed with the AMF (French Financial Markets Authority) on April 26, 2016.

2015 Annual Results

2015 Annual Results

Registration Document 2014

Registration Document 2014

2014 annual results

Sustained growth, Reference products drive growth in 2014.
<br />
2014 key figures.

Reference Document 2013

Reference Document 2013

2013 annual results

SFAF meeting March 13, 2014

Vétoquinol : 80 years striving for animal health worldwide

Founded in 1933, Vétoquinol is now a leading global animal health company.
The number 10 global animal health company and the third
largest in France, the Vétoquinol Group combines sustainability,
growth and independence in an increasingly competitive world
market.
Committed to the protection and well-being of both animals
and people, Vétoquinol creates, develops and sells veterinary
drugs and non-medical products all over the world.
The company is widely reputed for its expertise in the fields of infectious diseases, pain and inflammation in livestock (cattle and pigs) and pets (dogs and cats).
For over 80 years, Vétoquinol's pursuit of growth has been underpinned by strong values of team spirit, performance and the sharing of corporate culture and know-how with customers, vets, breeders, partners and employees alike.